ClinicalTrials.govpublic full text
A Study of the Efficacy and Safety of Upadacitinib in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies
crohn's disease, upadacitinib, abt-494, efficacy, safety, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 835768
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.